(paliperidone palmitate) modified release injectable suspension
The information contained in this learning resource contains a portion of the product information. For full details see the product information by each product owner. A full list can be found in the References tab.
Schizophrenia in adults after they have been adequately treated with:
Yes3
No3
Initial INVEGA HAFYERA dose is based on previous INVEGA SUSTENNA or INVEGA TRINZA dose.3
Initiate INVEGA HAFYERA when the next INVEGA SUSTENNA or INVEGA TRINZA dose is scheduled.3
100 mg INVEGA SUSTENNA --> initiate INVEGA HAFYERA at 700 mg
150 mg INVEGA SUSTENNA --> initiate INVEGA HAFYERA at 1000 mg
350 mg INVEGA TRINZA --> initiate INVEGA HAFYERA at 700 mg
525 mg INVEGA TRINZA --> initiate INVEGA HAFYERA at 1000 mg3
Notes:
INVEGA HAFYERA may be administered up to 7 days before or after the monthly time point of the next scheduled INVEGA SUSTENNA dose.
INVEGA HAFYERA may be administerd up to 14 days before or after the 3-monthly time point of the next scheduled INVEGA TRINZA dose.3
Schizophrenia in adults after they have been adequately treated with:
No3
Prefilled syringe3
INVEGA HAFYERA is a highly concentrated product and requires specific steps to resuspend. Proper shaking can reduce the likelihood for an incomplete injection and storing the carton in a horizontal position improves the ability to resuspend this product. Shake the syringe containing INVEGA HAFYERA very fast for at least 15 seconds. Rest briefly, then shake again for another 15 seconds. To ensure complete resuspension, shake syringe with short, very fast up and down motion and with a loose wrist. A properly resuspended product will be uniform, thick, and milky white.3
Note: INVEGA HAFYERA requires longer and faster shaking than INVEGA SUSTENNA.3
If more than 5 minutes pass after initial shaking before injection, shake very fast again for at least 30 seconds to resuspend the medication.3
23
Single-dose, prefilled syringe kit
INVEGA HAFYERA (paliperidone palmitate) doses hydrolyze to the following amounts of the active moiety (paliperidone):3
1092 mg - 1560 mg Q6M3
3.5 mL (1092 mg dose) - 5 mL (1560 mg dose):3
1.53
203
IM (gluteal only)3
n/a
20 gauge, 1.5-inch safety needle3
n/a
Prefilled syringe3
Single-dose, prefilled syringe kit
1 single-dose, prefilled syringe containing INVEGA HAFYERA aqueous suspension
+
1 thin-walled safety needle for drug administration3
+
tip cap
+
plunger rod
+
backstop
No3
Store below 25°C
Not stated in PI
Not stated in PI
Store in a horizontal position. See arrows on product carton for proper orientation.
Room Temperature3
INVEGA HAFYERA is a highly concentrated product and requires specific steps to resuspend. Proper shaking can reduce the likelihood for an incomplete injection and storing the carton in a horizontal position improves the ability to resuspend this product. Shake the syringe containing INVEGA HAFYERA very fast for at least 15 seconds. Rest briefly, then shake again for another 15 seconds. To ensure complete resuspension, shake syringe with short, very fast up and down motion and with a loose wrist. A properly resuspended product will be uniform, thick, and milky white.3
Note: INVEGA HAFYERA requires longer and faster shaking than INVEGA SUSTENNA.3
If more than 5 minutes pass after initial shaking before injection, shake very fast again for at least 30 seconds to resuspend the medication.3
By clicking the button below you agree to the following:
I understand that S.C.O.P.E. is for educational purposes only and not to be used for the treatment or diagnosis of schizophrenia, nor is it a substitute for clinical judgment or guidelines.